Johnson & Johnson (NYSE: JNJ) Q1 2021 earnings call dated Apr. 20, 2021
Corporate Participants:
Christopher DelOrefice — Vice President of Investor Relations
Joseph J. Wolk — Executive Vice President and Chief Financial Officer
Paul Stoffels — Vice Chairman of the Executive Committee and Chief Scientific Officer
Alex Gorsky — Chairman, Board of Directors and Chief Executive Officer
Joaquin Duato — Vice Chairman of the Executive Committee
Analysts:
Chris Schott — J.P. Morgan — Analyst
Larry Biegelsen — Wells Fargo — Analyst
Joanne Wuensch — Citi — Analyst
Bob Hopkins — Bank of America Merrill Lynch — Analyst
Joshua Jennings — Cowen and Company — Analyst
Louise Chen — Cantor Fitzgerald — Analyst
Danielle Antalffy — SVB Leerink — Analyst
Matt Miksic — Credit Suisse — Analyst
Terence Flynn — Goldman Sachs — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Infographic: How UnitedHealth Group (UNH) performed in Q1 2025
UnitedHealth Group (NYSE: UNH) reported its first quarter 2025 earnings results today. Total revenues were $109.6 billion compared to $99.8 billion in the same quarter a year ago. Net earnings
INFY Earnings: Infosys Q4 profit drops despite an increase in revenues
Infosys (NYSE: INFY) Thursday reported an increase in revenues for the fourth quarter of 2025. However, Q4 profit declined year-over-year. The software firm’s revenues increased 3.6% year-over-year to $4.73 billion
AXP Earnings: Key quarterly highlights from American Express’ Q1 2025 financial results
American Express Company (NYSE: AXP) reported its first quarter 2025 earnings results today. Consolidated total revenues net of interest expense were $17 billion, up 7% year-over-year. Revenues grew 8% on
Listen On
